Investigational Drug Information for LY3556050
✉ Email this page to a colleague
What is the drug development status for LY3556050?
LY3556050 is an investigational drug.
There have been 6 clinical trials for LY3556050.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 20th 2021.
The most common disease conditions in clinical trials are Chronic Pain, Low Back Pain, and Back Pain. The leading clinical trial sponsors are Eli Lilly and Company and [disabled in preview].
Summary for LY3556050
| US Patents | 0 |
| International Patents | 30 |
| US Patent Applications | 8 |
| WIPO Patent Applications | 1 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2021-05-20) |
| Vendors | 3 |
Recent Clinical Trials for LY3556050
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Effect of LY3556050 on Metformin in Healthy Participants | Eli Lilly and Company | Phase 1 |
| Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain | Eli Lilly and Company | Phase 2 |
| Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain | Eli Lilly and Company | Phase 2 |
Clinical Trial Summary for LY3556050
Top disease conditions for LY3556050
Top clinical trial sponsors for LY3556050
US Patents for LY3556050
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for LY3556050
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| LY3556050 | Argentina | AR096339 | 2033-05-17 | ⤷ Try a Trial |
| LY3556050 | Australia | AU2014267328 | 2033-05-17 | ⤷ Try a Trial |
| LY3556050 | Brazil | BR112015028452 | 2033-05-17 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
